Research Output per year
Fingerprint Dive into the research topics where Raushan T Kurmasheva is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 4 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
Dose-response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium
Gill, J., Zhang, W., Zhang, Z., Roth, M., Harrison, D. J., Rowshan, S., Erickson, S., Gatto, G., Kurmasheva, R., Houghton, P., Teicher, B., Smith, M. A., Kolb, E. A. & Gorlick, R., 2020, (Accepted/In press) In : Pediatric Blood and Cancer.Research output: Contribution to journal › Article
Evaluation of eribulin combined with irinotecan for treatment of pediatric cancer xenografts
Robles, A. J., Kurmasheva, R. T., Bandyopadhyay, A. M., Phelps, D. A., Erickson, S. W., Lai, Z., Kurmashev, D., Chen, Y., Smith, M. A. & Houghton, P. J., Jun 15 2020, In : Clinical Cancer Research. 26, 12, p. 3012-3023 12 p.Research output: Contribution to journal › Article
Evaluation of VTP-50469, a menin-MLL1 inhibitor, against Ewing sarcoma xenograft models by the pediatric preclinical testing consortium
Kurmasheva, R. T., Bandyopadhyay, A., Favours, E., Pozo, V. D., Ghilu, S., Phelps, D. A., McGeehan, G. M., Erickson, S. W., Smith, M. A. & Houghton, P. J., Jul 1 2020, In : Pediatric Blood and Cancer. 67, 7, e28284.Research output: Contribution to journal › Article
Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium
Harrison, D. J., Gill, J. D., Roth, M. E., Zhang, W., Teicher, B., Erickson, S., Gatto, G., Kurmasheva, R. T., Houghton, P. J., Smith, M. A., Kolb, E. A. & Gorlick, R., Jun 1 2020, In : Pediatric Blood and Cancer. 67, 6, e28222.Research output: Contribution to journal › Article
Preclinical evaluation of the combination of AZD1775 and irinotecan against selected pediatric solid tumors: A Pediatric Preclinical Testing Consortium report
Kolb, E. A., Houghton, P. J., Kurmasheva, R. T., Mosse, Y. P., Maris, J. M., Erickson, S. W., Guo, Y., Teicher, B. A., Smith, M. A. & Gorlick, R., May 1 2020, In : Pediatric Blood and Cancer. 67, 5, e28098.Research output: Contribution to journal › Article
Press / Media
University of Texas Health Science Center at San Antonio: CPRIT Awards Mays Cancer Center More Than $10.3 Million
Raushan T Kurmasheva, Luiz O Penalva, Dmitri N Ivanov, Manjeet K Rao & Mingjiang Xu
8/21/20
1 item of Media coverage
Press/Media: Press / Media
Preclinical drug development for childhood cancers
Peter J Houghton & Raushan T Kurmasheva
11/28/19
1 item of Media coverage
Press/Media: Press / Media
WIPO PUBLISHES PATENT OF THE BOARD OF REGENTS OF UNIVERSITY OF TEXAS SYSTEM FOR "NANOPARTICLE COMPOSITIONS AND METHODS OF USE OF PARP INHIBITOR FOR TREATMENT OF CANCER" (AMERICAN INVENTORS)
10/31/19
1 item of Media coverage
Press/Media: Press / Media
Innovative genomics and bioinformatics research at the Greehey Institute
Yidong Chen, Manjeet K Rao, Peter J Houghton & Raushan T Kurmasheva
6/18/19
1 item of Media coverage
Press/Media: Press / Media
Epizyme : to Present New Scientific Data on the Role of HMT Inhibitors in Cancer
11/4/15
2 items of Media coverage
Press/Media: Press / Media